A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Young Adult Survivors United
Eli Lilly and Company
Washington University School of Medicine
Elevation Oncology
Washington University School of Medicine
Cellestia Biotech AG
pharmaand GmbH
Pfizer
Roswell Park Cancer Institute
MacroGenics
Seagen Inc.
InSightec
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Yale University
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
Western Regional Medical Center
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Pfizer
Emory University
Case Comprehensive Cancer Center